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Digital health is the convergence of technology with healthcare
delivery and is a new field in public health and clinical medicine. It
is the use of information and communications technologies to
improve human health and healthcare services.1 There has been
increased adoption of health care technologies by the general pub-
lic in recent years.2 This was made possible with the advent of
mobile technology, fast broadband, 4G internet and the falling
price of technology devices. Digital health can be used for point-
of-care support, emergency medical responses, reminders for
clinical appointments, reporting test results, health promotion,
data collection for research, real-time data streaming, disease
modelling, personalised care, and public health interventions.1
Numerous modalities for digital communication exist such as
smartphones and computers with two-way cameras, web-based
portals, e-mails, interactive voice response, social media platforms,
online forums and personal monitoring devices.3
These modalities have been adapted to provide different types
of digital health technologies that have overlapping roles in deliv-
ering healthcare. The major modalities that patients use within
their homes include telehealthcare and mHealth. Telehealthcare
leverages telecommunication, video imaging, and information
technologies. It enables health care practitioners to provide medi-
cal services virtually. Telehealthcare can address social, cultural
and geographical inequalities in healthcare delivery through non-
encounter communication.4 It has been especially useful for
remote monitoring of elderly patients within their homes.5
mHealth, on the other hand, is concerned with the role of
mobile technology in delivering health services.6 mHealth uses
mobile applications or short message services (SMS) to reach andengage with patients remotely. mHealth interventions are mobile
and popular, providing novel long-term disease management
solutions for patients.7,8 However, they are not without their chal-
lenges. Many mHealth technologies require an internet connection
to operate fully. While the use of technology has dramatically
increased worldwide in recent years, as of 2017, only 64.5% of
the global population own a mobile phone while less than 50%
have access to internet services.9 These figures are concerning as
disadvantaged groups may not be able to engage with digital
health interventions. Health economists have highlighted that
access to the internet services and its content depends on five fac-
tors: affordability, availability, accessibility, accommodation and
acceptability.10 As with other health care services, mHealth inter-
ventions must be readily available and accessible to the patients
who need them most and offered at a price they can afford. With-
out maintaining this balance, health inequalities will arise from
mHealth technologies. If widespread access is achieved, digital
health interventions may solve critical public health dilemmas
such as chronic and non-communicable diseases prevention and
management.
Chronic and non-communicable diseases account for the largest
group of public health issues in the European region11 and cost the
European Union countries 115 billion euros collectively each
year.12 The most frequently targeted chronic and non-communica-
ble diseases include type 2 diabetes, asthma, chronic obstructive
pulmonary disease (COPD), cardiovascular diseases, cancer, and
mental health problems.13 Without adherence to management
plans, these diseases and illnesses gravely affect patients’ quality
of life.14,15 Innovative and cost-effective solutions, that allow
patients to self-manage illnesses are urgently needed to solve
these issues and lessen the financial burden on healthcare systems
worldwide.
Evidence suggests that mHealth technologies produce mixed
clinical outcomes for patients in the management of chronic and
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tematic reviews is needed to investigate the benefit of mHealth
interventions for chronic disease prevention and management. To
the best of our knowledge, this study will be the first to do so.
Study aim
The main aim of this overview is to study the impact of mHealth
interventions on chronic disease management among patients. It
will also explore patients’ engagement with mHealth technologies
and highlight barriers that may hinder their use.
Methods
The PICOS approach, an abbreviation for participants, interven-
tions, comparators, outcomes, and study design will be used in this
review.18
Types of participants
Systematic reviews looking at patients suffering from chronic
diseases will be included in the overview. No age limit or geo-
graphic location restriction will be imposed. Systematic reviews
that only target health care practitioners or families of patients
using mHealth technologies will not be included.
Types of interventions
This overview will target chronic disease interventions that are
delivered using mHealth technologies. For this study, mHealth is
defined as technological interventions that use smartphone
applications or mobile text-messaging services to deliver health-
care. These interventions must be delivered to patients in a
home-based setting. Social media interventions will not be
included in this review due to the privacy issues associated with
these technologies.
Types of outcomes
The following outcomes will be reported and discussed:
Primary outcomes
a) Sociodemographic of patients
b) Cost efficiency of using the mHealth intervention
c) Changes in health outcomes after using the intervention
d) Patients’ adherence to and engagement with the
intervention
e) Adverse events or barriers to using the intervention
Secondary outcomes
a) Patients’ perception of using the intervention
b) Quality and reliability of the intervention
c) Patients’ follow-up with healthcare services after using
intervention
Types of studies
Systematic reviews of quantitative studies will be included in
this review, including randomised control trials, case-controls,
cohort studies and cross-sectional studies. Systematic reviews that
explore qualitative studies will be excluded. Reviewsmust be peer-
reviewed and published in English. Only systematic reviews that
are published after 2008 will be included. Given the fast-paced nat-
ure of technological development, restricting studies to the lastdecade will ensure that only the most recent knowledge is
reported and analysed.
Data search strategy
To identify studies for this review, the following electronic data-
bases will be used:
 MEDLINE
 CINAHL
 EMBASE
 Cochrane Database of Systematic Reviews
 Google Scholar (first one-hundred citations)
Searches will be carried out using both indexed terms and free
text. Search terms will be adjusted for each electronic database. To
identify grey literature, the WHO’s Library Database (WHOLIS) and
the Web of Science Conference Proceedings Citation Index will be
used. Reference lists of full-text studies that are included in the
final review will also be checked for other potentially eligible stud-
ies. The proposed terms are as followsIntervention terms Disease terms Study design– digital health⁄
– mobile
health/mHealth
– ehealth
smartphone/mobile
phone
– mobile application⁄
– short message
service/SMS
– telehealth/telecare/
telemedicine– chronic
disease⁄/illness⁄
– non-communi-
cable disease
– long-term
disease⁄
– Cardiovascular
disease⁄
– Diabetes⁄
– chronic obstruc-
tive pulmonary
disease/COPD
– Hypertension– systematic
review
– reviewThe search strategy will be: (digital health⁄ OR Mobile health OR
mHealth or eHealth or smartphone OR mobile phone OR mobile
application⁄ OR short message service OR SMS OR telehealth OR
telecare OR telemedicine) AND (chronic disease⁄ OR illness⁄ OR
non-communicable disease OR long-term disease⁄ OR cardiovascu-
lar disease⁄ OR diabetes⁄ OR chronic obstructive pulmonary disease
OR COPD OR hypertension) AND (systematic review OR review).
Data collection
All studies that are identified by the search strategy will be
screened against the inclusion criteria (Table 1). RefWorks, a refer-
ence management software, will help sort the data and duplicate
publications will be removed. Titles and abstracts will be screened
initially.19 Those that fit the eligibility criteria will move onto the
next phase of the review. The full text of these studies will be
obtained and read. Only studies that fully match the inclusion
criteria will be included in the final stage of the review (Table 1).
During the selection process, a Prisma flow diagram will be used
to show the number of studies excluded at each stage of the selec-
tion process.
Quality assessment and data extraction
As the methodological rigour of the final studies is expected to
vary, quality will be assessed using the Measurement Tool to
Assess Systematic Reviews (AMSTAR) checklist for systematic
Table 1
Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Language Papers written in English Any other language
Study period Studies conducted and published in or after 2008 Studies conducted or published before 2008
Type of study Systematic reviews of quantitative research Any other types of reviews
Patient demographics Patients with chronic diseases Other users such as health care practitioners or family members
Types of intervention Mobile health interventions such as SMS or mobile
applications
Any other form of alternative health interventions
Setting of intervention Home-based setting Clinic or hospital setting
Included diseases Chronic, communicable or life-long diseases such as Diabetes,
COPD, cardiovascular diseases and Hypertension
Any other acute illnesses or other medical conditions
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each study’s generalisability, statistical issues or bias as well as
the strength and quality of the reported data. Two reviewers will
assess quality independently and studies of low-quality will be
removed from the review to maintain high-quality output.
Data extraction will be guided by a data extraction form which
has been created specifically for this overview. The key features
that will be extracted onto this form include: year of publication,
main research questions or objectives, setting and location, popu-
lation characteristics, number of included studies, types of mobile
interventions used, types of chronic diseases it addresses and the
primary and secondary study outcomes. If a study has missing
information the authors will be contacted directly for clarification.
Both the quality assessment tool and the data extraction form will
be piloted on a sample of studies to ensure that they capture all the
relevant information.
Data synthesis
Data analysis will be through narrative synthesis and will be
descriptive.21 A summary of the findings of the included studies
will be produced, as a detailed tabular presentation. The following
characteristics will be described: type of mHealth intervention,
type of chronic disease as well as target population characteristics
such as summary of age groups, gender, ethnicity, education level,
socioeconomic status and country setting. Where possible, data
will be summarised using the standard mean difference or mean
difference with a 95% confidence interval (CI). Evidence that is
high-quality will be given priority, and results that indicate poten-
tial bias will be interpreted with caution.
Conclusion
This overview of systematic reviews will provide a detailed
summary of the evidence regarding mHealth interventions on
chronic disease management for patients. This information will
add to the current body of knowledge and will be used to inform
policy and practise towards the uptake of mHealth technologies
among health care providers and their patients.
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